These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15712245)

  • 1. Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector.
    Mima H; Tomoshige R; Kanamori T; Tabata Y; Yamamoto S; Ito S; Tamai K; Kaneda Y
    J Gene Med; 2005 Jul; 7(7):888-97. PubMed ID: 15712245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes.
    Tashiro H; Aoki M; Isobe M; Hashiya N; Makino H; Kaneda Y; Ogihara T; Morishita R
    J Mol Cell Cardiol; 2005 Sep; 39(3):503-9. PubMed ID: 16040050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
    Kaneda Y
    Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a transferrin receptor-targeting HVJ-E vector.
    Shimbo T; Kawachi M; Saga K; Fujita H; Yamazaki T; Tamai K; Kaneda Y
    Biochem Biophys Res Commun; 2007 Dec; 364(3):423-8. PubMed ID: 17961511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of HVJ envelope vector and its application to gene therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total vascular exclusion safely facilitates liver specific gene transfer by the HVJ (sendai virus)-liposome method in rats.
    Kawashita Y; Fujioka H; Ohtsuru A; Kuroda H; Eguchi S; Kaneda Y; Yamashita S; Kanematsu T
    J Surg Res; 2006 May; 132(1):136-41. PubMed ID: 16337969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin.
    Ito M; Yamamoto S; Nimura K; Hiraoka K; Tamai K; Kaneda Y
    J Gene Med; 2005 Aug; 7(8):1044-52. PubMed ID: 15756713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.
    Kawano H; Komaba S; Kanamori T; Kaneda Y
    BMC Med; 2007 Sep; 5():28. PubMed ID: 17883878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of HVJ-liposome mediated gene transfer in lung transplantation-distribution and transfection efficiency in the lung.
    Ohmori K; Takeda S; Miyoshi S; Minami M; Nakane S; Ohta M; Sawa Y; Matsuda H
    Eur J Cardiothorac Surg; 2005 May; 27(5):768-73. PubMed ID: 15848312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector.
    Suvanasuthi S; Tamai K; Kaneda Y
    J Gene Med; 2007 Jan; 9(1):55-62. PubMed ID: 17149789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional modification of Sendai virus by siRNA.
    Saga K; Tamai K; Kawachi M; Shimbo T; Fujita H; Yamazaki T; Kaneda Y
    J Biotechnol; 2008 Feb; 133(3):386-94. PubMed ID: 18093677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.
    Fujii H; Matsuyama A; Komoda H; Sasai M; Suzuki M; Asano T; Doki Y; Kirihata M; Ono K; Tabata Y; Kaneda Y; Sawa Y; Lee CM
    Radiat Oncol; 2011 Jan; 6():8. PubMed ID: 21247507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system.
    Kaneda Y; Nakajima T; Nishikawa T; Yamamoto S; Ikegami H; Suzuki N; Nakamura H; Morishita R; Kotani H
    Mol Ther; 2002 Aug; 6(2):219-26. PubMed ID: 12161188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HVJ liposomes and HVJ envelope vectors.
    Kaneda Y
    Cold Spring Harb Protoc; 2011 Oct; 2011(10):1281-9. PubMed ID: 21969614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector.
    Morishita N; Nakagami H; Morishita R; Takeda S; Mishima F; Terazono B; Nishijima S; Kaneda Y; Tanaka N
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1121-6. PubMed ID: 16134237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of HVJ Envelope Vector and Its Application to Gene Therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53PA():307-332. PubMed ID: 16243069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives.
    Zhang Q; Li Y; Shi Y; Zhang Y
    Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector.
    Mima H; Yamamoto S; Ito M; Tomoshige R; Tabata Y; Tamai K; Kaneda Y
    Mol Cancer Ther; 2006 Apr; 5(4):1021-8. PubMed ID: 16648574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
    Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
    Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.